1.305
Evogene Ltd stock is traded at $1.305, with a volume of 16,853.
It is up +2.35% in the last 24 hours and up +0.38% over the past month.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.
See More
Previous Close:
$1.275
Open:
$1.29
24h Volume:
16,853
Relative Volume:
0.01
Market Cap:
$11.56M
Revenue:
$5.64M
Net Income/Loss:
$-23.88M
P/E Ratio:
-2.4623
EPS:
-0.53
Net Cash Flow:
$-22.36M
1W Performance:
-3.33%
1M Performance:
+0.38%
6M Performance:
-7.90%
1Y Performance:
-63.24%
Evogene Ltd Stock (EVGN) Company Profile
Compare EVGN with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
EVGN
Evogene Ltd
|
1.305 | 11.56M | 5.64M | -23.88M | -22.36M | -0.53 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-08-21 | Initiated | ROTH Capital | Buy |
Jul-29-21 | Initiated | Aegis Capital | Buy |
Dec-01-20 | Initiated | Cantor Fitzgerald | Overweight |
Dec-16-13 | Initiated | Oppenheimer | Outperform |
Evogene Ltd Stock (EVGN) Latest News
Evogene Ltd (EVGN) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Shifts Amid ... - ca.finance.yahoo.com
Evogene Ltd. Reports Improved Revenue Amidst Losses - TipRanks
Evogene Announces Q2 2025 Financial Results and Strategic Shift to AI - MSN
Evogene: Q2 Earnings Snapshot - Norwalk Hour
Evogene's Q2 2025: Unraveling Contradictions in Castor Seed Strategy and Financial Outlook - AInvest
Evogene Q2 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Evogene’s Q2 2025 results reveal significant cost cuts - Investing.com
Evogene Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Momentum Screeners Rank Evogene Ltd. in Top 5 TodayJuly 2025 Highlights & Proven Capital Preservation Methods - classian.co.kr
Evogene's Earnings Dilemma: A Cautionary Tale for Biotech Innovation - AInvest
Evogene Reports Second Quarter 2025 Financial Results - PR Newswire
Evogene Shareholders Approve Proposals at Annual Meeting - TipRanks
How does Evogene Ltd. correlate with Nasdaq2025 Earnings Impact & Free Safe Entry Trade Signal Reports - thegnnews.com
Heatmap analysis for Evogene Ltd. and competitors2025 Earnings Impact & Momentum Based Trading Ideas - Newser
Should you hold or exit Evogene Ltd. now2025 Retail Activity & Precise Swing Trade Entry Alerts - Newser
Can Evogene Ltd. rally from current levelsJuly 2025 Recap & High Conviction Buy Zone Picks - Newser
Evogene (EVGN) Projected to Post Quarterly Earnings on Tuesday - Defense World
Will Evogene Ltd. see short term momentumRate Cut & High Return Trade Opportunity Guides - Newser
Should you wait for a breakout in Evogene Ltd.Market Movement Recap & Entry Point Confirmation Signals - Newser
Can momentum traders help lift Evogene Ltd.2025 Top Gainers & Daily Oversold Bounce Ideas - Newser
What MACD and RSI say about Evogene Ltd.CEO Change & Fast Momentum Stock Entry Tips - Newser
What risks could impact Evogene Ltd. stock performancePortfolio Growth Summary & Daily Technical Stock Forecast Reports - Newser
Identifying reversal signals in Evogene Ltd.July 2025 Volume & Daily Growth Stock Tips - Newser
Trend analysis for Evogene Ltd. this weekCEO Change & AI Driven Price Predictions - Newser
Visualizing Evogene Ltd. stock with heatmapsJuly 2025 Recap & Fast Gain Swing Alerts - Newser
Can swing trading help recover from Evogene Ltd. lossesJuly 2025 Closing Moves & High Accuracy Swing Entry Alerts - Newser
What candlestick patterns are forming on Evogene Ltd.Market Trend Summary & Reliable Entry Point Trade Alerts - Newser
Volume spikes in Evogene Ltd. stock – what they meanJuly 2025 Opening Moves & Community Verified Watchlist Alerts - Newser
Momentum divergence signals in Evogene Ltd. chartEarnings Risk Summary & Community Verified Watchlist Alerts - Newser
Is Evogene Ltd. still worth holding after the dip2025 Major Catalysts & AI Powered Buy/Sell Recommendations - Newser
Evogene Ltd. recovery potential after sell offJuly 2025 Summary & Free Safe Entry Trade Signal Reports - Newser
Predicting Evogene Ltd. trend using moving averagesPortfolio Value Report & Free Accurate Trade Setup Notifications - Newser
Evogene Ltd. Matches Institutional Buying FilterTrade Ideas & Fast Entry High Yield Tips - kangso.co.kr
Evogene Ltd expected to post a loss of 45 cents a shareEarnings Preview - TradingView
Evogene Ltd. stock daily chart insightsMarket Sentiment Review & Community Trade Idea Sharing - Newser
Applying chart zones and confluence areas to Evogene Ltd.July 2025 Intraday Action & Safe Entry Point Alerts - Newser
Evogene Ltd. Reaches Critical Trendline SupportJuly 2025 Macro Moves & Step-by-Step Swing Trade Plans - beatles.ru
Evogene (NASDAQ:EVGN) Upgraded at Alliance Global Partners - Defense World
Is Evogene Ltd. vulnerable to short sellers2025 Earnings Impact & Consistent Income Trade Ideas - thegnnews.com
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases - StreetInsider
Is Evogene Ltd. likely to announce a buybackFast Money Trade Selections - 한국정경신문
Price Consolidation Hints at Upcoming Move in Evogene Ltd.Conservative Long Term Growth Plans Under Review - sundaytimes.kr
Evogene Ltd. and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases - MarketScreener
Evogene partners with Tel Aviv University to develop metabolic disease treatments - Investing.com Nigeria
Evogene partners with Tel Aviv University to develop metabolic disease treatments By Investing.com - Investing.com South Africa
Evogene and Tel Aviv University collaborate on drug discovery for metabolite-related diseases. - AInvest
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases – Company AnnouncementFT.com - Financial Times
How Evogene Ltd. stock performs during market volatilityBuy and Hold Strategy for Capital Safety - Newser
Can Evogene Ltd. maintain sales growthSmart Entry for Explosive Returns - mustnews.co.kr
Has Evogene Ltd. Stock Ever Crashed Historical Volatility ReviewDownside Control Plan With Support Analysis - Newser
Trapped Investors in Evogene Ltd. Await Breakout SignalVerified Signal From Chart Patterns Detected - beatles.ru
Evogene Ltd Stock (EVGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):